Table 4.
Combination of tumor markers | No. of cases (%) |
---|---|
1. CA15‐3/CEA/NCCST‐439 positive | 44 (29.9%) |
2. Midkine/CA15‐3/CEA positive | 66 (44.9%) |
3. Midkine/CA15‐3/NCCST‐439 positive | 61 (41.5%) |
4. Midkine/CEA/NCCST‐439 positive | 66 (44.9%) |
1 vs 2, P < 0.0001; 1 vs 3, P = 0.0031; 1 vs 4, P < 0.0001 (McNeman test).